On Thursday morning, the Supreme Court issued its decision in FDA v. Alliance for Hippocratic Medicine. Justice Kavanaugh wrote for a unanimous Court dismissing the Alliance for Hippocratic Medicine from the case for lack of...more
6/14/2024
/ Abortion ,
Alliance for Hippocratic Medicine v Food and Drug Administration ,
Article III ,
FDA Approval ,
Food and Drug Administration (FDA) ,
Patient Access ,
Pharmaceutical Industry ,
Prescription Drugs ,
Reproductive Healthcare Issues ,
SCOTUS ,
Standing
On March 26, 2024, the Supreme Court heard arguments in the two consolidated cases concerning access to mifepristone pending before the Court, FDA v. Alliance for Hippocratic Medicine, Case No. 23-235 and Danco Laboratories,...more
Medication abortions using mifepristone and misoprostol now account for more than half of all abortions performed in the United States today. In the post-Dobbs era, medication abortion is critical to reproductive rights...more